Carter Discusses Obamacare Ruling

| June 29, 2015

Carter Buddy

Buddy Carter, US Congressman, First District of Georgia

The only thing worse for health care in America than Obamacare has been its implementation which clearly ignores the rule of law.

In a 6-3 ruling, the U.S. Supreme Court this week upheld controversial subsidies offered by the Obama Administration’s Internal Revenue Service to individuals purchasing insurance on federally-maintained health care exchanges.
While this ruling is a deep disappointment to those who, like me, have seen the devastating impact of this train wreck of a law first hand, we cannot lose hope that we will prevail in repealing and replacing it with real reforms.

To that end, I joined the Republican Study Committee’s Health Care Task Force earlier this year in introducing H.R. 2653, the American Health Care Reform Act, to fully repeal Obamacare and create patient-centered reforms while bringing the free market back into our health care system.

Among the reforms in the proposal are provisions that would:

  • provide the same tax benefits to those purchasing health care coverage on the individual market as those with employer-sponsored coverage;
  • expand federal support for high-risk pools and expand portability to increase insurance access for those with pre-existing conditions;
  • allow for the purchase of health insurance across state lines; and
  • give small businesses the ability to pool together to negotiate better rates.

With these commonsense, market-oriented reforms, we can empower all Americans to have access to quality health care coverage without expanding the role of government in our lives. In contrast, Obamacare empowers government bureaucrats to drive up cost, take away choice, and eliminate innovation in the system.

As the only pharmacist in Congress, I pledge to redouble my efforts to repeal and replace Obamacare.

Lawsuit to Be Filed Against Georgia’s “Certificate of Need” Law
Guilty Verdict in Lee County Murder Trial
Filed in: News, Regional News

Comments are closed.